Investigation of proteasome inhibition combined with tyrosine kinase inhibition as a therapeutic option for triple-negative breast cancer 
MU Researcher: Mgr. Lenka Bešše, Ph.D.
Project Period: 1/2026 — 12/2029
Investor: Ministry of Health of the CR / Ministry of Health Research Programme 2024 - 2030

CRISPR Activation Screening to Identify Surface Proteins Modulating Cytotoxic T Cell Responses in Multiple Myeloma
MU Researcher: Mgr. Andrej Bešše, Dr. sc. nat.
Project Period: 1/2026 — 12/2029
Investor: Ministry of Health of the CR / Ministry of Health Research Programme 2024 - 2030

ECPAS-Mediated Proteasome Remodeling as a Mechanism of Resistance to Proteasome Inhibition in Multiple Myeloma 
MU Researcher: Mgr. Lenka Bešše, Ph.D.
Project Period: 1/2026 — 12/2028
Investor: Czech Science Foundation / Standard Projects

National institute for cancer research 
MU Researcher: doc. Mgr. Jiří Šána, Ph.D.
Project Period: 6/2022 — 12/2025
Investor: Ministry of Education, Youth and Sports of the CR / national recovery plan